Newswise Feature Channel: Addiction

Exposure to Marijuana in the Womb May Increase Risk of Addiction to Opioids Later in Life, Study Finds

University of Maryland School of Medicine — Wed, 13 Nov 2024 17:00:56 EST

University of Maryland School of Medicine Researchers Identify Neurobiological Changes Leading to Increase Release of the Brain Chemical Dopamine and Its Target Neurons Linked to Addiction-Like Behavior With the increased legalization of recreational cannabis, as many as 1 in 5 pregnant women in the U.S. are now using the drug to help with morning sickness, lower back pain or anxiety.

Pennsylvania Legislators to Address Xylazine Crisis at Free Medical Symposium

The Rothman Orthopaedic Institute Foundation for Opioid Research and Education — Wed, 13 Nov 2024 09:35:50 EST

Pennsylvania legislators and top medical experts will come together to address the growing xylazine crisis at an upcoming free symposium. The event, titled "The Next Chapter of the Opioid Epidemic in Pennsylvania: The Xylazine Crisis," will be held on November 23, 2024, at the Bluemle Life Science Building at Jefferson Med in Philadelphia.

New Evidence-Based Information from NCCN Offers Tangible and Moral Support for People Trying to Quit Smoking

National Comprehensive Cancer Network(r) (NCCN(r)) — Wed, 13 Nov 2024 08:00:36 EST

Newly-published NCCN Guidelines for Patients: Quitting Smoking explains what the evidence and expert consensus is on how to best use the tools that exist to help anyone quit for good.

Study: Online E-Cigarette Retailers Fail to Comply with Sale Regulations

University of California San Diego — Mon, 11 Nov 2024 11:00:00 EST

Online e-cigarette retailers are not consistently adhering to laws aimed at preventing the sale of vaping products to minors, including regulations on age verification, shipping methods and flavor restrictions, report researchers at the Herbert Wertheim School of Public Health and Human Longevity Science at University of California San Diego.

Mount Sinai Awarded Nearly $7 Million From National Institutes of Health to Create New York Coalition to Recruit for Highly Diverse Health Database

Mount Sinai Health System — Mon, 11 Nov 2024 09:45:33 EST

Health System to serve as lead site for the All of Us research program

Hackensack Meridian JFK Johnson Rehabilitation Institute: Leading the Way in PM&R Innovation at AAPMR 2024

Hackensack Meridian Health — Mon, 04 Nov 2024 11:00:29 EST

Hackensack Meridian JFK Johnson Rehabilitation Institute, a nationally recognized leader in physical medicine and rehabilitation, is proud to announce its participation in the upcoming American Academy of Physical Medicine And Rehabilitation Annual Assembly (AAPMR) 2024 Annual Assembly, taking place November 6-10 in San Diego, CA.

UC San Diego Awarded $8 Million to Uncover Genetic Foundations of Substance Use Disorders

University of California San Diego — Mon, 28 Oct 2024 11:00:06 EST

UC San Diego has received a five-year, $8 Million grant to support a NIDA P30 Center to investigate the genetics, genomics, and epigenetics behind substance use disorders.

Opioids May Negatively Impact Hormone Health

Endocrine Society — Thu, 24 Oct 2024 10:40:02 EST

A new Scientific Statement released today by the Endocrine Society highlights research gaps associated with the negative effects of opioid use on the endocrine system.

Implantable Device May Prevent Death From Opioid Overdose

Washington University in St. Louis — Wed, 23 Oct 2024 14:00:00 EST

Researchers from WashU Medicine and Northwestern University developed an implantable device that can detect an overdose and rapidly deliver naloxone.

A 37% Drop in Overdose Deaths From Drugs Mixed with Opioids - Fentanyl Included

Ohio State University — Mon, 21 Oct 2024 11:55:26 EST

Expanded treatment options, increased naloxone distribution and targeted education campaigns likely led to a 37% reduction in overdose deaths from opioids combined with stimulant drugs other than cocaine, according to the results of a large federally funded study.

Brain Imaging of Neuromelanin May be Key to Understanding Extensive Substance Use

Stony Brook University — Wed, 16 Oct 2024 13:00:47 EST

A study that used a specialized type of magnetic resonance imaging (MRI), named neuromelanin-sensitive MRI, showed that this type of MRI signal was increased in regions of the midbrain in young adults ages 20 to 24 who had an extensive alcohol and drug use history. The findings are published early online in the American Journal of Psychiatry.

Men and Women Use Different Biological Systems to Reduce Pain

University of California San Diego — Wed, 16 Oct 2024 09:00:41 EST

According to new research from UC San Diego School of Medicine, men and women rely on different biological systems for pain relief, which could help explain why our most powerful pain medications are often less effective in women.

Researchers Putting CBD to the Test From Behind the Wheel

West Virginia University — Tue, 15 Oct 2024 09:05:02 EST

As cannabidiol products -- commonly known as CBD -- become more readily available, West Virginia University researchers are working to gain a broader understanding of how the substance influences driving performance and whether the effects differ between men and women.

Expert Available: DEA's Move to Reclassify Marijuana Sparks Debate on Health, Access, and Research

George Washington University — Thu, 10 Oct 2024 12:00:02 EST

In response to President Biden's call to reclassify marijuana, the DEA began the process of rescheduling marijuana from a Schedule I to Schedule III drug. ...

UA Little Rock Receives $5 Million to Combat Drug Use Among Arkansas Youth

University of Arkansas at Little Rock — Thu, 10 Oct 2024 09:05:47 EST

The University of Arkansas at Little Rock has received $5 million in federal funding to address the growing drug and opioid crisis among youth in Arkansas. The award comes from appropriations language authored by U.S. Sen. John Boozman passed into law in 2024. The funding is administered by the Office of National Drug Control Policy.

Top Experts Unite at University of Bristol to Tackle Gambling Harms Globally

University of Bristol — Wed, 09 Oct 2024 04:05:14 EST

Leading experts from across the world will join forces in the UK this week in a bid to confront the wide-reaching challenges and curb the devastating effects of gambling.

Rothman Orthopaedic Institute Foundation to Host Symposium on Xylazine Crisis in Pennsylvania

The Rothman Orthopaedic Institute Foundation for Opioid Research and Education — Mon, 07 Oct 2024 10:05:01 EST

The Rothman Orthopaedic Institute Foundation for Opioid Research & Education announces a symposium titled "The Next Chapter of the Opioid Epidemic in Pennsylvania: The Xylazine Crisis" to be held on November 23, 2024, from 8:30 am to 12:30 pm at the Bluemle Life Science Building at Jefferson Med in Philadelphia.

Study Reveals Sources of Opioid Poisoning Among Children

Rutgers University-New Brunswick — Wed, 25 Sep 2024 09:05:32 EST

Rutgers Health research finds the medications of grandparents and pets, as well as discarded items, pose unexpected hazards for young children.

Patients with Alcohol Use Disorder at Risk of Liver Disease May be Less Commonly Referred for Liver Treatment if they are primarily seen for Mental Health Disorders

Research Society on Alcoholism — Sat, 21 Sep 2024 10:00:00 EST

People with alcohol use disorder (AUD) who are at risk of advanced liver disease are less likely to be referred for liver evaluation and care if they present primarily with alcohol-related mental health issues or a mental health diagnosis, according to a study of referral practices in Virginia's largest health system. The findings point to the possibility of widespread missed opportunities for treating three conditions that commonly co-occur: AUD, mental health disorders, and liver disease. Recent years have seen notable increases in the USA in alcohol-related deaths, mental health disorders, and hospital admissions relating to alcohol use and concurrent mental health conditions. AUD is a significant cause of liver disease, and both addiction and co-occurring mental illness can be barriers to successful liver treatment. Integrating AUD treatment, mental health care, and hepatology (liver care) is necessary to improve outcomes, but data suggests this approach is not the norm. For the st

Ultra-Low-Dose Ketamine Can Curb Opioid Withdrawal

University of Washington School of Medicine and UW Medicine — Tue, 17 Sep 2024 13:05:04 EST

Research findings published Aug. 29 in Addiction Science & Clinical Practice may offer hope. A pilot study showed that a small amount of ketamine can reduce or eliminate the withdrawal symptoms associated with quitting fentanyl.